// App-Quantinova.ai

P409 : FMT induced increase in gut microbial diversity and Clostridia is associated with clinical response in patients with ulcerative colitis – results from STOP Colitis trial

Researchers

Presenter

  • Quraishi, M.N

Principal Investigators

  • Quince, C

  • Hewitt, C

  • Beggs, A

  • Gerasimidis , K

  • Sharma, N

  • Hawkey, P

  • Oo, Y

  • Ives, N

  • Manzoor, S

  • Loman, N

  • Hansen, R

  • Hart, A

  • Gaya, D

  • Iqbal, T

Medical Centers

  • University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Gastroenterology, Birmingham, United Kingdom

  • Earlham Institute, Norwich Research Park, Norwich, UK

  • Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Beatson Institute, Cancer Division, University of Glasgow, Glasgow, United Kingdom

  • Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, United Kingdom

  • Department of Paediatric Gastroenterology, Royal Hospital for Sick Children, Glasgow, UK

  • Department of Pediatric Anesthesiology, Great Ormond Street Hospital,NHS, London, United Kingdom

  • Gastrointestinal Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Ophthalmology (OP)

  • Genetic Disorder

Disease

  • Ulcerative colitis

  • Coloboma of optic nerve

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved